Connect
MJA
MJA

Hormone replacement therapy after a diagnosis of breast cancer: cancer recurrence and mortality

Theresa M Hayes, Craig R Underhill, Kerrie Clarke and Martin HN Tattersall
Med J Aust 2003; 178 (8): 412-413.
Published online: 21 April 2003

To the Editor: We urge caution about the recently published findings of Durna and colleagues on use of hormone replacement therapy (HRT) by breast cancer patients.1 They found no increase in risk of breast cancer recurrence or reduction in life expectancy in women using HRT after treatment for primary breast cancer, leading them to conclude that HRT seems a safe treatment for women with a history of breast cancer. We believe that their study has many limitations and consequently their conclusions are unfounded

  • Theresa M Hayes
  • Craig R Underhill
  • Kerrie Clarke
  • Martin HN Tattersall


Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.